文献

J-GLOBAL ID：201602210710149650   整理番号：16A0106016

治療中のダプトマイシン耐性黄色ブドウ球菌の発生

Emergence of Daptomycin-Resistant Staphylococcus aureus during Treatment

著者 (10件)： HAGIYA Hideharu (Dep. of General Medicine, Okayama Univ. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, JPN) ,  HARUKI Yuto (Dep. of Pharmacy, Tsuyama Chuo Hospital, JPN) ,  UCHIDA Taeko (Dep. of Clinical Microbiology, Graduate School of Clinical Pharmacy, Shujitsu Univ., JPN) ,  WADA Tomoko (Dep. of Pharmacy, Tsuyama Chuo Hospital, JPN) ,  WADA Tomoko (Dep. of Clinical Microbiology, Graduate School of Clinical Pharmacy, Shujitsu Univ., JPN) ,  SHIOTA Sumiko (Dep. of Clinical Microbiology, Graduate School of Clinical Pharmacy, Shujitsu Univ., JPN) ,  ISHIDA Tomoharu (Dep. of General Medicine, Okayama Univ. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, JPN) ,  OGAWA Hiroko (Dep. of General Medicine, Okayama Univ. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, JPN) ,  MURASE Tomoko (Dep. of Clinical Lab., Microbiology Div., Tsuyama Chuo Hospital, JPN) ,  OTSUKA Fumio (Dep. of General Medicine, Okayama Univ. Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, JPN)
資料名： Internal Medicine (Web)  (Internal Medicine (Web))
巻： 55  号： 1  ページ： 73-78 (J-STAGE)  発行年： 2016年 
JST資料番号： U0033A  ISSN： 1349-7235  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： 日本 (JPN)  言語： 英語 (EN)

抄録/ポイント： 巨大腸腰筋膿瘍,化膿性脊椎炎,椎間板炎,メチシリン耐性黄色ブ...

シソーラス用語： ヒト ,...
準シソーラス用語： カテーテル感染 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=16A0106016&from=J-GLOBAL&jstjournalNo=U0033A") }}

分類 (1件)： 感染症・寄生虫症の治療  (GD01030D)

物質索引 (4件)： ダプトマイシン ,  バンコマイシン ,  メロペネム ,  リネゾリド

引用文献 (33件)：

• 1. Silverman JA, Perlmutter NG, Shapiro HM. Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother 47: 2538-2544, 2003.
• 2. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52: e18-e55, 2011.
• 3. Fowler VG Jr, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 355: 653-665, 2006.
• 4. Sakoulas G, Alder J, Thauvin-Eliopoulos C, et al. Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin. Antimicrob Agents Chemother 50: 1581-1585, 2006.
• 5. Suzuki M, Tawada Y, Kato M, et al. Development of a rapid strain differentiation method for methicillin-resistant Staphylococcus aureus isolated in Japan by detecting phage-derived open-reading frames. J Appl Microbiol 101: 938-947, 2006.

タイトルに関連する用語 (4件)： 治療 ,  ダプトマイシン ,  耐性 ,  黄色ブドウ球菌